Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

2.

Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias.

Lane RF, Shineman DW, Fillit HM.

Alzheimers Res Ther. 2011 Dec 15;3(6):36. doi: 10.1186/alzrt99.

3.
5.

The 14th International Conference on Alzheimer's Drug Discovery, 9 - 10 September 2013, in Jersey City, New Jersey.

Glicksman MA.

Expert Opin Drug Discov. 2014 Feb;9(2):215-20. doi: 10.1517/17460441.2014.877441.

PMID:
24444088
7.

Proceedings of the 10th International Conference on Alzheimer's Drug Discovery. September 14-15, 2009. Jersey City, New Jersey, USA.

[No authors listed]

Curr Alzheimer Res. 2010 May;7(3):188-279. No abstract available.

PMID:
20687240
8.
9.

Partnership between academia and industry for drug discovery in Alzheimer's disease.

Ivinson AJ, Lane R, May PC, Hosford DA, Carrillo MC, Siemers ER.

Alzheimers Dement. 2008 Mar;4(2):80-8. doi: 10.1016/j.jalz.2008.02.004. Erratum in: Alzheimers Dement. 2008 May;4(3):230-1.

PMID:
18631952
10.
11.

Perspectives from the world's largest Alzheimer's disease research conference: Stockholm, Sweden, July 2002.

Ward Robinson J, Halderman S.

Curr Womens Health Rep. 2002 Oct;2(5):394-6.

PMID:
12215313
12.

Alzheimer's disease: from pathology to therapeutic approaches.

Jakob-Roetne R, Jacobsen H.

Angew Chem Int Ed Engl. 2009;48(17):3030-59. doi: 10.1002/anie.200802808. Review.

PMID:
19330877
13.

Drug discovery in the 21st century.

Pollastri MP.

Future Med Chem. 2011 Dec;3(16):1979-81. doi: 10.4155/fmc.11.151.

14.

Alzheimer's disease: new approaches to drug discovery.

Bolognesi ML, Matera R, Minarini A, Rosini M, Melchiorre C.

Curr Opin Chem Biol. 2009 Jun;13(3):303-8. doi: 10.1016/j.cbpa.2009.04.619. Epub 2009 May 19. Review.

PMID:
19467915
15.

Drug Discovery for Neurodegeneration - inaugural Alzheimer's Drug Discovery Foundation meeting.

Fallon L.

IDrugs. 2007 Apr;10(4):233-6. No abstract available.

PMID:
17390241
17.

Defining and Measuring Outcomes in Alzheimer's Disease: Do We Agree? Proceedings of a conference. Washington, D.C., USA. September 11-12, 1996.

[No authors listed]

Alzheimer Dis Assoc Disord. 1997;11 Suppl 6:1-198. No abstract available.

PMID:
9498851
18.

[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis].

Sugimoto H.

Yakugaku Zasshi. 2010 Apr;130(4):521-6. Review. Japanese.

19.

Maximizing the Alzheimer's Disease Neuroimaging Initiative II.

Carrillo MC, Sanders CA, Katz RG.

Alzheimers Dement. 2009 May;5(3):271-5. doi: 10.1016/j.jalz.2009.02.005. Epub 2009 Apr 11.

PMID:
19362888
20.

Alzheimer's Association International Conference on Alzheimer's Disease 2015 (AAIC 2015) (July 18-23, 2015 - Washington, D.C., USA).

Mason VL.

Drugs Today (Barc). 2015 Jul;51(7):447-52. doi: 10.1358/dot.2015.51.7.2375989.

PMID:
26261847

Supplemental Content

Support Center